Dr. Beaupre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 813-974-0706Fax+1 813-974-4325- Is this information wrong?
Education & Training
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2003
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1997 - 1999
- McGovern Medical School at UTHealthClass of 1997
Certifications & Licensure
- FL State Medical License 1998 - 2025
Clinical Trials
- Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma Start of enrollment: 2005 Aug 01
- Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL) Start of enrollment: 2011 Feb 01
- Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 11 citationsModulation of RNA splicing enhances response to BCL2 inhibition in leukemia.Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian Stahl, Simon J Hogg, Jan Phillipp Bewersdorf, Cuijuan Han, Michael E Singer, Da...> ;Cancer Cell. 2023 Jan 9
- 8 citationsNavigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion RecommendationsElly Barry, Jaimie A Walsh, Scott L. Weinrich, Darrin M. Beaupre, Eileen R. Blasi, Daniel Ray Arenson, Ira Jacobs> ;Paediatric Drugs. 2021 Jun 26
- 7 citationsPhase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma.Wyndham H. Wilson, Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy S. Kimball, Darrin M. Beaupre, Da-Wei Huang, George E. Wright, Kevin A. Kwei, J...> ;Leukemia & Lymphoma. 2021 Apr 15
- Join now to see all
Press Mentions
- IDEAYA Announces IND Clearance Enabling Phase 1/2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP-Deletion Solid TumorsMay 22nd, 2023
- IDEAYA Doses First Patient in Phase L HRD Solid Tumour Therapy TrialApril 19th, 2023
- IDEAYA Biosciences, Inc. Reports 2022 Financial Results and Provides Business UpdateMarch 7th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: